A little-known gene can affect your breast cancer risk, even if you don’t have BRCA mutations
- An under-recognized genetic mutation is linked to an increased risk of breast
- New guidelines recommend screening for the variant, which can inform choices like mastectomies.
- The mutation, to the PALB2 gene, also boosts the risk of ovarian and pancreatic cancers.
Experts are raising awareness of a little-known genetic mutation that can boost a person's risk of breast cancer 40% to 60%. The gene, called PALB2, hasn't received the same attention as the BRCA1 and BRCA2 genes, which are linked to a higher cancer risk, especially among people of Ashkenazi Jewish decent.
Now, scientists are urging clinicians to screen for PALB2 mutations in anyone undergoing genetic tests for breast cancer risk, according to The New York Times. The information could lead patients to choose preventive mastectomies or more closely monitor their breast
A PALB2 mutation can up your cancer risk by five-fold
A large 2021 study found that people with breast-cancer-linked-BRCA variants - which Angelina Jolie famously had, leading to her double mastectomy - were 5.2 to 7.6 as likely to develop breast cancer than those without the mutations. For people with the PALB2 mutation, rates are 3.8- to 5-fold.
As a result, new guidance from the American College of Medical
A person's risk for cancer with the PALB2 mutation is influenced by family history. The guidelines say that 76% of women with the mutation who have two or more first-degree relatives who've had breast cancer will develop the disease by 80. The mutation also ups the likelihood of ovarian and pancreatic cancer.
The new guidelines recommend people with the PALB2 mutation get alternating MRIs and mammograms every six months, as well as pancreatic screenings - especially if they have a family history of pancreatic cancer.
Some doctors are unaware of the gene's link to cancer
Scientists linked PALB2 mutations to a significant increase in breast cancer risk in 2014, but lagging research and expensive genetic tests have held clinicians back from readily screening patients for it. In some cases, they're not even aware the gene exists.
46-year-old Seattle resident Heidi Marsh got tested for the PALB2 mutation after learning her mom had it, according to The New York Times. Marsh said her doctor wasn't aware of the gene and the referred oncologist didn't recommend surgery.
But after finding a team of clinicians who knew about the gene, Marsh decided to have her fallopian tubes, where ovarian cancers can begin, removed and to undergo regular breast screenings. She's also planning an MRI of her pancreas, the Times reported.
"This was not remotely on my radar screen," Marsh told the Times. "In one sense I feel empowered. But I also feel like I am waiting for the other shoe to drop, that cancer will be inevitable."
- ₹10 lakh crore - that's how much banks wrote off in the last 5 years
- Indian markets will wait for cues from US inflation data
- India issues more pilot licenses as its air traffic increases
- Indian diamantaires want to make lab-grown diamonds a woman’s best friend
- MSME credit demand jumps 60% from pre-pandemic levels – a sign of rebound in economic activity